CBR1 overexpression can also protect leukemic cells from As O23 by regulating reactive oxygen species production while inhibiting CBR1 expression enhances the effect of As O23 on therapeutic sensitivity in a variety of leukemia cell lines (24). This evidence concerns the gene CBR1 and leukemia.